142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

315355
ASTHO's President's Challenge

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014 : 9:10 AM - 9:30 AM

Terry Cline, PhD , State Department of Public Health, State of Oklahoma, Oklahoma City, OK
Every year the incoming Association of State and Territorial Health Officials (ASTHO) president introduces a Challenge for state health officials to focus attention on a critical national health issue. Last September, ASTHO president Terry Cline’s Challenge was to reduce the rate of nonmedical use and the number of unintentional overdose deaths involving controlled prescription drugs 15 percent by 2015. Lessons Learned: The Challenge galvanized support for state health officials, governmental state agencies, national partners, and others to identify interventions supporting a comprehensive framework spanning prevention, surveillance, enforcement, treatment and recovery.

Learning Areas:

Public health administration or related administration
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy

Learning Objectives:
Discuss how the ASTHO Presidentís Challenge mobilized action to address prescription drug misuse, abuse, and overdose using a comprehensive public health approach. Identify three types of policies and/or programs that state health agencies pledged to conduct. Describe promising state strategies or outcomes reported by state health officials.

Keyword(s): Public Health Administration, Public Health Research

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Terry Cline Ph.D. is Commissioner of the Oklahoma Department of Health and President of the ASTHO Board. As President of the ASTHO Board, his challenge is to reduce the prescription drug abuse deaths 15% by 2015. As a psychologist, he has seen the rate of misuse and deaths attributed to misuse of prescriptions and has worked throughout his career on this issue.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.